BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with boomrx #peptides #fda #compoundingpharmacy #clinicalmedicine #patientaccess BoomRX peptides #fda #longevity #glp1 #precisionmedicine #compounding Katherine Erickson The Sikiric Problem: One Lab, Thirty Years, Zero Trials That Matter FDA May Reverse Ban on 14 PeptidesWhat It Means for Your Beauty Routine Allure